Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 single-arm study of human fibrinogen in congenital fibrinogen deficiency
ChiCTR2300076477Phase 3Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Fibrinogen human in fibrinogen deficiency, sponsored by Institute of Hematology and Blood Diseases Hospital. Primary endpoint: Recovery of fibrinogen activity at 1.5 hours after the start of first infusion. Started Dec 2019; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiency
Beyond the preview
Go deeper on ChiCTR2300076477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076477.